Journal of Clinical Epidemiology
Volume 50, Issue 5 , Pages 547-556 , May 1997

Assessing individual risk for breast cancer: Risky business

  • Anne McTiernan

      Affiliations

    • Corresponding Author InformationAddress for correspondence: Anne McTiernan, Cancer Prevention Research Program, MP-1002, Fred Hutchinson Cancer Research Center, 1124 Columbia Street, Seattle, WA 98104.
    • Cancer Prevention Research Program, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA
    • ,
  • Mary Ann Gilligan

      Affiliations

    • Cancer Prevention Research Program, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA
    • Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA
    • ,
  • Carol Redmond

      Affiliations

    • Department of Biometry and Epidemiology, College of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA

,Accepted 7 February 1997.

References 

  1. Taplin S, Thompson RS, Schnitzer F, et al.  Revisions in the risk-based breast cancer screening program at Group Health Cooperative. Cancer. 1990;66:812–818
  2. Vogel V. High-risk populations as targets for breast cancer prevention trials. Prev Med. 1991;20:86–100
  3. Henderson M, Kushi L, Thompson D, et al.  Feasibility of a randomized trial of a low-fat diet for the prevention of breast cancer: Dietary compliance in the Women's Health Trial vanguard study. Prev Med. 1990;19:115–133
  4. Lerman C, Lustbader E, Rimer B, et al.  Effects of individualized breast cancer risks counseling: A randomized trial. J Natl Cancer Inst. 1995;87:286–292
  5. Miki Y, Swenson J, Shattuck-Eidens D, et al.  A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 1994;266:66–71
  6. In: Cancer Statistics Review 1973–1989. 2nd edition.  Miller BA,  Ries LAG,  Hankey BF, et al. editor. NIH Pub. No. 92-2789. Bethesda, MD: USDHHS, PHS, NIH, NCI; 1992;
  7. Claus EM, Risch NM, Thompson WD. Age at onset as an indicator of familial risk of breast cancer. Am J Epidemiol. 1990;131:961–972
  8. Claus E. Genetic epidemiology of breast cancer in younger women. Monogr Natl Cancer Inst. 1994;16:49–53
  9. Bodian CA. Benign breast diseases, carcinoma in-situ, and breast cancer risk. Epidemiol Rev. 1993;15:177–187
  10. Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med. 1985;312:146–151
  11. Kelsey JL, Gammon MD, John EM. Reproductive factors and breast cancer. Epidemiol Rev. 1993;15:36–47
  12. Taplin S, Anderman C, Grothaus L. Breast cancer risk and participation in mammographic screening. Am J Public Health. 1989;79:1494–1498
  13. Dawson DA, Thompson GB. Breast cancer risk factors and screening: United States, 1987. National Center for Health Statistics. Vital Health Stat. 1989;10:1–32
  14. White E. Projected changes in breast cancer incidence due to the trend toward delayed childbearing. Am J Public Health. 1987;77:495–497
  15. Kelsey JL. A review of the epidemiology of human breast cancer. Epidemiol Rev. 1979;1:74–109
  16. Wingo PA, Tong T, Bolden S. Cancer Statistics 1995. CA-A Cancer J Clinicians. 1995;45:8–30
  17. Rosenberg L, Metzger LS, Palmer JR. Alcohol consumption and risk of breast cancer: A review of the epidemiologic evidence. Epidemiol Rev. 1993;15:133–144
  18. Berkelman RL, Ralston M, Herndon J, et al.  Patterns of alcohol consumption and alcohol-related morbidity and mortality. MWWR CDC Surveill Summ. 1986;135:1SS–5SS
  19. Boice JD, Monson RR. Breast cancer in women after repeated fluoroscopic examinations of the chest. J Natl Cancer Inst. 1977;59:823–832
  20. Tokunaga M, Land CE, Yamamoto T, et al.  Incidence of female breast cancer among atomic bomb survivors, Hiroshima and Nagasaki, 1950–1980. Radiat Res. 1987;112:243–272
  21. John EM, Kelsey JL. Radiation and other environmental exposures and breast cancer. Epidemiol Rev. 1993;15:157–162
  22. Hunter DJ, Willett WC. Diet, body size, and breast cancer. Epidemiol Rev. 1993;15:110–132
  23. Life Sciences Research Office . Federation of American Societies for Experimental Biology. In: 2nd edition. Nutrition Monitoring in the United States: An Update Report on Nutrition Monitoring. Hyattsville, MD: FASEB; 1989;
  24. Steinberg KK, Thacker SB, Smith J, et al.  A meta-analysis of the effect of estrogen replacement therapy on the risk of breast cancer. JAMA. 1991;265:1985–1990
  25. Colditz GA, Hankinson SE, Hunter DJ, et al.  The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med. 1995;332:1589–1593
  26. Stanford J, Weiss NS, Daling JR, et al.  Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women. JAMA. 1995;274:137–142
  27. Newcomb PA, Longnecker MP, Storer BE, et al.  Long-term hormone replacement therapy and risk of breast cancer in postmenopausal women. Am J Epidemiol. 1995;142:788–795
  28. Derby CA, Hume AL, Barbour MM. Correlates of postmenopausal estrogen use and trends through the 1980s in two southeastern New England communities. Am J Epidemiol. 1993;137:1125–1135
  29. Malone KE, Daling JR, Weiss NS. Oral contraceptives in relation to breast cancer. Epidemiol Rev. 1993;15:80–97
  30. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormonal contraceptives: Collaborative reanalysis of individual data on 53,297 women with breast cancer and 100,239 women without breast cancer from 54 epidemiological studies. Lancet. 1996;347:1713–1727
  31. Daling JR, Malone KE, Voigt LF, White E, Weiss N. Risk of breast cancer among young women: Relationship to induced abortion. J Natl Cancer Inst. 1994;86:1584–1592
  32. McTiernan A, Thomas B. Evidence for a protective effect of lactation on risk of breast cancer in young women. Am J Epidemiol. 1986;124:353–358
  33. Newcomb PA, Storer BE, Longnecker MP, et al.  Lactation and a reduced risk of premenopausal breast cancer. N Engl J Med. 1994;330:81–87
  34. Prentice R, Sheppard L. Dietary fat and cancer: Consistency of the epidemiological data, and disease prevention that may follow from a practical reduction in fat consumption. Cancer Causes & Control. 1990;1:81–97
  35. Bernstein L, Henderson BE, Hanisch R, et al.  Physical exercise and reduced risk of breast cancer in young women. J Natl Cancer Inst. 1994;86:1403–1408
  36. McTiernan A, Stanford J, Weiss NS, et al.  Occurrence of breast cancer in relation to recreational exercise in women aged 50–64 years. Epidemiology. 1996;7:598–604
  37. D'Avanzo D, Nanni O, LaVecchia C, et al.  Physical activity and breast cancer risk. Cancer Epidemiol Biom Prev. 1996;5:155–160
  38. Ottman R, Pike MC, King MC, et al.  Practical guide for estimating risk for familial breast cancer. Lancet. 1983;ii:556–558
  39. Anderson DE, Badzioch MD. Risk of familial breast cancer. Cancer. 1985;56:383–387
  40. Bernstein JL, Thompson WD, Risch N, et al.  The genetic epidemiology of second primary breast cancer. Am J Epidemiol. 1992;136:937–948
  41. Ford D, Easton DF, Bishop DT, et al.  Breast Cancer Linkage Consortium. Risk of cancer in BRCA-1 mutation carriers. Lancet. 1994;343:692–695
  42. Claus EB, Risch N, Thompson WD. Autosomal dominant inheritance of early-onset breast cancer: Implications for risk prediction. Cancer. 1994;73:643–651
  43. Gail MH, Brinton LA, Byar DP, et al.  Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst. 1989;81:1879–1886
  44. National Surgical Adjuvant Breast and Bowel Project . NSABP Protocol P-1: A Clinical Trial to Determine the Worth of Tamoxifen for Preventing Breast Cancer. Pittsburgh, PA: NSABP; 1992;
  45. Bernichou J. A computer program for estimating individualized probabilities of breast cancer. Computers and Biomedical Research. 1993;26:373–382
  46. Bernichou J, Gail MH, Mulvikill JJ. Graphs to estimate an individualized risk of breast cancer. J Clin Oncol. 1996;14:103–110
  47. Baker LH. Breast cancer detection demonstration project: Five-year summary report. Cancer. 1982;32:194–225
  48. Gail MH, Benichou J. Assessing the risk of breast cancer in individuals. In:  DeVita VT,  Hellman S,  Rosenberg SA editor. Cancer Prevention. Philadelphia, PA: Lipincott; 1992;p. 1–15
  49. Bondy ML, Lustbader ED, Halabi S, et al.  Validation of a breast cancer risk assessment model in women with a positive family history. J Natl Cancer Inst. 1994;86:620–625
  50. Speigelman D, Colditz GA, Hunter D, Hertzmark E. Validation of the Gail et al. Model for predicting individual breast cancer risk. JNCI. 1994;86:600–607
  51. Bruzzi P, Green SB, Byar DP, et al.  Estimating the population attributable risk for multiple risk factors using case-control data. Am J Epidemiol. 1985;122:904–914
  52. Alexander FE, Roberts MM, Huggins A. Risk factors for breast cancer with applications for selection for the prevalence screen. J Epidemiol Comm Hlth. 1987;41:101–106
  53. Schecter MT, Miller AB, Baines CJ, et al.  Selection of women at high risk of breast cancer for initial screening. J Chron I. 1986;39:253–260
  54. Soini I, Hakama M. Failure of selective screening for breast cancer by combining risk factors. Int J Cancer. 1978;22:275–281
  55. Toti A, Piffanelli A, Oacanelli T, et al.  Possible indication of breast cancer risk through discriminant function. Cancer. 1980;46:1280–1285
  56. Easton DF, Ford D, Bishop DT, The Breast Cancer Linkage Consortium . Breast and ovarian cancer incidence in BRCA1-mutation carriers. Am J Hum Genet. 1995;56:265–271
  57. Powles TJ, Hardy JR, Ashley SE, et al.  A pilot trial to evaluate the acute toxicity and feasibility of tamoxifen for prevention of breast cancer. Br J Cancer. 1989;60:126–131
  58. Vogel VG. High-risk populations as targets for breast cancer prevention trials. Prev Med. 1991;20:86–100
  59. Bondy ML, Vogel VG, Halabi S, et al.  Identification of women at risk for breast cancer in a population-based screening program. Cancer Epidemiol, Biomarkers and Prev. 1992;1:143–147
  60. Newman B, Austin MA, Lee M, King M-C. Inheritance of human breast cancer: Evidence for autosomal dominant transmission in high-risk families. In: 2nd edition. Proc Natl Acad Sci USA. 85:1988;p. 3044–3048

☆ This work was supported in part by grant number RO1 HG/CA 011 01 from the National Center for Human Genome Research and National Cancer Institute, and grant number 1-R25-CA-5773 from the National Cancer Institute, National Institutes of Health.

PII: S0895-4356(97)00013-9

Journal of Clinical Epidemiology
Volume 50, Issue 5 , Pages 547-556 , May 1997

Article Tools